针对公众对澳大利亚注意力缺陷多动障碍(ADHD)治疗药物可能引发精神病的担忧,最新分析指出,在规范处方和监测条件下,此类风险实际上非常低 1。数据显示,2023-24年度,每1000名澳大利亚人中约有22人获得政府补贴的ADHD药物,涉及总人数接近60万 1。在这些处方中,兴奋剂类药物占比高达87% 1。尽管ADHD药物的使用量随着诊断率的上升而增加,但综合证据表明其益处显著且安全性较高,主要的伤害风险往往源于非处方滥用或非医疗用途,如高剂量摄入、吸食或注射 1。
多项大规模研究进一步量化了这一风险。在规范治疗环境下,兴奋剂诱发精神病的比例仅为0.2%至3%,这一数值低于许多其他精神障碍在普通人群中的患病率 1。一项涵盖超过22万名青少年的美国研究发现,约每660人在开始服用兴奋剂后的几个月内出现精神病症状 1。另一项整合了16项研究、涉及39万人的综合分析显示,处方兴奋剂导致精神病症状的总体风险为2.8% 1。值得注意的是,两项基于人群的研究指出,安非他命类药物的精神病发生率约为甲基苯丙胺的两倍 1。为此,文章作者Adam Guastella、Kelsie Boulton和Timothy Chen建议患者应依赖专业评估,严格遵医嘱服药并定期接受监测,以确保护理安全 1。
Despite growing concerns in Australia that stimulant medications for attention deficit hyperactivity disorder (ADHD) may induce psychosis, evidence suggests the risk is minimal when drugs are prescribed and monitored correctly 1. During the 2023-24 period, approximately 22 out of every 1,000 Australians received government-subsidized ADHD medication, totaling nearly 600,000 individuals 1. Stimulants accounted for 87% of these prescriptions 1. In controlled clinical settings, the incidence of stimulant-induced psychosis ranges from 0.2% to 3%, a rate lower than the prevalence of many mental disorders in the general population 1.
Large-scale studies further contextualize this risk. A U.S.-based analysis of over 220,000 adolescents found that psychosis developed in about one in 660 people within months of starting stimulant treatment 1. Additionally, a synthesis of 16 studies covering 390,000 participants indicated an overall risk of 2.8% for psychosis symptoms resulting from prescribed stimulants 1. Research also highlights differences among drug types, with two population-based studies showing that amphetamine-class medications carry a psychosis rate roughly double that of methamphetamine 1. However, authors Adam Guastella, Kelsie Boulton, and Timothy Chen emphasize that significant risks arise primarily from non-prescribed use, high-dose intake, or illicit methods such as snorting or injecting 1. They advise patients to rely on professional evaluations, adhere strictly to medical instructions, and undergo regular monitoring to ensure safety 1.
评论
还没有评论,欢迎留下第一条。